Survival Impact of Pathological Residual Patterns for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy
Journal of Hepato-Biliary-Pancreatic Sciences · 25.06.2026
DOI: 10.1002/jhbp.70146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, online erschienen am 25.06.2026. Verfasst von Hidetaka Miyazaki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreatobiliary Surgery, Kansai Medical University, Osaka, Japan. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Background
With increasing use of neoadjuvant therapy (NAT) for pancreatic ductal adenocarcinoma (PDAC), accurate pathological response system is essential. Although the College of American Pathologists (CAP) grading is widely used, its prognostic utility remains limited.
Methods
This retrospective study included 206 patients with resectable or borderline resectable PDAC who underwent pancreatectomy following NAT. Pathological residual patterns were morphologically classified into three categories—type I (concentric distribution of residual tumor without any surrounding lesions), type II (concentric distribution with surrounding lesions), type III (residual multinodular lesions)—with types I, II grouped as the concentric type, and types III as the multinodular type.
Results
The concentric type had significantly longer median overall survival (OS: 133 vs. 32 months) and disease‐free survival (DFS: 32 vs. 18 months) compared with the multinodular type (both p < 0.001). Residual patterns was an independent prognostic factor for OS (HR: 1.78, p = 0.017), whereas CAP grading was not ( p = 0.142). Residual patterns also provided superior prognostic discrimination, with higher Harrell's C ‐index for OS than CAP grading (0.711 vs. 0.595; p = 0.047).
Conclusion
Pathological residual patterns may serve as a practical prognostic indicator after NAT.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pancreatobiliary Surgery, Kansai Medical University, Osaka, Japan.
- Department of Pathology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
- Department of Surgery, Trung Vuong Hospital, Ho Chi Minh City, Vietnam.
- Department of Hepatobiliary and Pancreatic Surgery, Institute of Science Tokyo, Tokyo, Japan.
- Department of Pathology, Kansai Medical University, Osaka, Japan.
- Division of Surgical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
ORCID-Profile: Hidetaka Miyazaki, Hiroyuki Ishida, Katsunori Uchida, Daisuke Hashimoto, Sohei Satoi
Zitieren
APA
Miyazaki, H., Ishida, M., Yamaki, S., Sang, N. T., Matsumura, K., Ishida, H., Matsui, Y., Uchida, K., Hashimoto, D., & Satoi, S. (2026). Survival Impact of Pathological Residual Patterns for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.70146
Vancouver
Miyazaki H, Ishida M, Yamaki S, Sang NT, Matsumura K, Ishida H, et al. Survival Impact of Pathological Residual Patterns for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy. Journal of Hepato-Biliary-Pancreatic Sciences. 2026. doi:10.1002/jhbp.70146
BibTeX
@article{Miyazaki2026,
author = {Miyazaki, Hidetaka and Ishida, Mitsuaki and Yamaki, So and Sang, Nguyen Thanh and Matsumura, Kazuki and Ishida, Hiroyuki and Matsui, Yuki and Uchida, Katsunori and Hashimoto, Daisuke and Satoi, Sohei},
title = {Survival Impact of Pathological Residual Patterns for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy},
journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
year = {2026},
doi = {10.1002/jhbp.70146}
}
EUVIMED